AURORA BIO

Welcome to the Brand page for “AURORA BIO”, which is offered here for the mark consists of the wording aurora in larger type above the wording bio. to the left of the wording is an abstract representation of a synthetic peptide, featuring a spiral design made of connected lines and dots of various sizes.;diagnostic agents, preparations and substances for medical purposes; diagnostic agents for medical purposes, diagnostic scanning agents for in vivo use for detection and monitoring of systemic amyloid diseases, such as transthyretin amyloidosis, light chain amyloidosis and lect2 amyloidosis; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the field of systemic amyloid disease; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis and treatment of systemic amyloid disease; all of the aforesaid for human use;color is not claimed as a feature of the mark.;bio;.

Its status is currently believed to be active. Its class is unavailable. “AURORA BIO” is believed to be currently owned by “AURORA BIO, INC.”


Owner:
AURORA BIO, INC.
Owner Details
Description:
The mark consists of the wording AURORA in larger type above the wording BIO. To the left of the wording is an abstract representation of a synthetic peptide, featuring a spiral design made of connected lines and dots of various sizes.;Diagnostic agents, preparations and substances for medical purposes; diagnostic agents for medical purposes, diagnostic scanning agents for in vivo use for detection and monitoring of systemic amyloid diseases, such as transthyretin amyloidosis, Light Chain Amyloidosis and LECT2 Amyloidosis; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the field of systemic amyloid disease; Radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; Pharmaceutical preparations for use in diagnosis and treatment of systemic amyloid disease; all of the aforesaid for human use;Color is not claimed as a feature of the mark.;BIO;
Categories: